Hansen, Gerhard Henrik Armauer
Hansen, Gerhard Henrik Armauer
(b. Bergen, Norway, 29 July 1841; d. Florø, Norway, 12 February 1912)
bacteriology.
Hansen was the eighth of fifteen children. His mother was Elisabeth Concordia Schram, who was a member of a family of master joiners long established in Bergen. His father, Claus Hansen, was a wholesale merchant until the severe contraction of credit of 1848–1851 drove him into bankruptcy; he then worked as a cashier in a bank.
In 1859 Hansen began his medical studies at the University of Christiania (now Oslo). It was necessary for him to earn his own living while he was a student. He first taught at a girls’ school and later spent a year as substitute for the prosector of anatomy. He then began his own tuition courses in anatomy. In later years he said that during this period he had known neither physical nor mental fatigue and had found that he did his best work between six and eight in the morning. He passed his degree with honors in 1866 and completed his internship at the National Hospital in, Christiania. He then served as doctor to a community of some 6,000 fishermen at Lofoten, a group of islands off northern Norway.
In 1868 Hansen entered the service of the leprosy hospitals in Bergen. His new chief, Daniel Cornelius Danielssen, had, with C. W. Boeck, published the major work Om Spedalsked (“On Leprosy,” 1847) and had helped to establish Bergen as the European center for leprosy research. Danielssen, like other investigators of the time, regarded the affliction as hereditary (and was to continue to do so throughout his life). Hansen, however, quickly concluded on the basis of epidemiological studies that leprosy was a specific disease which must have a specific cause.
Bacteriology was then in its infancy. In 1870 Hansen received a grant that allowed him to travel to improve his knowledge of histopathology. He went to Bonn and later to Vienna. Returning to Norway, using primitive staining methods and working with biopsy specimens from patients with leprosy, Hansen in 1873 discovered the rod-shaped bodies—Mycobacterium leprae, sometimes called Hansen’s bacillus. By 1879 he was able, through the use of improved staining methods, to show great numbers of the rodshaped bodies typically aggregated in parallel cells. He believed the bacillus to be the causative agent of leprosy and thereby became the first investigator to suggest that a chronic disease might be caused by microorganisms. (The tuberculosis bacillus, for example, was not discovered until 1882.)
Hansen conducted many experiments to prove that his bacillus was indeed the cause of leprosy. He attempted to find a method of cultivating the Mycobacterium leprae on artificial media, without success. (The bacillus has not yet been cultivated in vitro.) He further tried to transmit leprosy to animals and humans; he failed in experiments on rabbits, and experimental reproduction of the disease has not so far been accomplished. In a less well-advised effort, Hansen inoculated the eye of a woman suffering from the neural form of the disease with material drawn from a leprous nodule of a patient suffering from the cutaneous form. There were no clinical consequences of the inoculation, but since Hansen had not asked permission to perform the experiment, he met with legal difficulties as a result of which he was removed from his post as resident physician of the Bergen leprosy hospitals in May 1880.
Hansen’s sentence was less severe than it might seem, however, since he was allowed to retain his position as leprosy medical officer for the entire country of Norway—an appointment conferred on him in 1875 and one that he held until his death. He was thus able to implement changes in the methods of control of Ieprosy in Norway—changes that had been in part made necessary by his own hypotheses concerning the etiology of the disease. The Norwegian Leprosy Act of 1877 and the amended act of 1885 were the fruits of his untiring work. Under these laws health authorities could order lepers to live in precautionary isolation away from their families (subsequent studies have shown leprosy to be a familial affliction); enforcement of the laws led to a quick and steady decline of the disease in Norway. There were 1,752 known cases of leprosy in Norway in 1875; by the beginning of the twentieth century there were 577 (that there are only four known today may well reflect generally improved economic and hygienic conditions). The word “hansenarium” was suggested to replace the still more standard “leprosarium.”
Hansen received many honors for his leprotic studies. He was elected honorary chairman of the first Conférence Internationale de la Lèpre, held in Berlin in 1897, and was president of the second such conference, held in Bergen in 1909. He was honorary chairman of the International Leprosy Committee, corresponding or honorary member of numerous scientific societies, and was decorated several times. In 1900 contributions toward a portrait bust of Hansen were solicited internationally; the bust was unveiled with great ceremony the following year.
While Hansen was chiefly known for his work on leprosy, he also played a role in the dissemination of Darwin’s ideas. He learned of Darwin’s doctrines during his trip to Vienna, early in his career, and he then set about to study Darwin’s books. He sought to emulate Darwin’s methods, which he considered a model of dispassionate observation; in 1886 he published a book on Darwinism in Norwegian. In his apostolic zeal for Darwin’s work, Hansen also gave numerous lectures and published articles in the popular press. These evoked a great sensation, especially from the clergy and religious organizations—who reacted violently against the “blasphemer” in their midst. Hansen was, however, devoid of philosophical speculations and had no aptitude for martyrdom. He did not acknowledge the attacks made against him; he continued to sit at his microscope, smoking his pipe, and do his work.
Hansen married Danielssen’s daughter, Stephanie Marie, on 7 January 1873; she died of pulmonary tuberculosis on 25 October of the same year. On 27 August 1875 he married Johanne Margrethe Tidemand, a widow related to almost the entire Bergen commercial patriciate. Their only child, a son, became a physician specializing in tuberculosis and in 1929 was appointed chief of the tuberculosis hospital in Bergen.
Hansen suffered the first symptoms of heart disease as early as 1900; in following years he had several severe heart attacks that confined him to bed for long periods of time. In the intervals of his illness, however, he continued to travel around the country on official inspection tours. In February 1912 he made such a trip to the fishing areas north of Bergen; in Florø, a little town on the western coast, he was invited to stay in the home of a friend, and it was there that he died. He was given a funeral at state expense; he had been president of the Bergen Museum and the ceremonoy took place from its hall.
BIBLIOGRAPHY
I. Original Works. Hansen’s most important works concerning the bacillus include “Undersøgelser angaaende Spedalskhedens Aarsager” (“Investigations Concerning the Etiology of Leprosy”), in Norsk magazin for laegevidenskaben, 3rd ser., 4 no. 9 (1874), supp. 1–88, case reports I—LIII; “On the Etiology of Leprosy,” in British and Foreign Medical Magazine, 55 (1875), 459–489; “Bacillus leprace,” in Virchow’s Arkiv für pathologische Anatomie und physiologie und für klinische Medizin, 79 (1880), 32–42; “Studien über Bacillus leprae,” Ibid., 90 (1882), 542–548; Leprosy. In Its Clinical and Pathological Aspects (Bristol, 1895), written with C. Looft; and “Lepra,” in Wilhelm Kolle and A. Wassermann, eds., Handbuch der pathogeneb Mikroorganismen, II (Jena, 1903), 178-203.
II. Secondary Literature. On Hansen and his work, see W. H. Feldman, “Gerhard Henrik Armauer Hansen. What Did He See and When?,” in International Journal of Leprosy, 33 (1965), 412–416; B. Helland-Haasen, “G. Armauer Hansen in Memoriam,” in Medical Review (Bergen), 29 (1912), 125–128; O. Lasser, “Gerhard Armauer Hansen,” ibid., 18 (1901), 193–198; C. Looft, “G. Armauer Hansen,” ibid., 29 (1912), 164–166; P. Pallamary, “Translation of Gerhard Armauer Hansen: Spedalskhedens Aarsager (Cause of Leprosy),” in International Journal of Leprosy, 23 (1955), 307-309.
The following works about Hansen were written by T. M. Vogelsang: Armauer Hansen og Spedalskhetens historie i Norge (“Armauer Hansen and the History of Leprosy in Norway”), Universitetet i Bergeny Småskrifter no. 12 (1962); “Hansen’s First Observation and Publication Concerning the Bacillus of Leprosy,” in. International Journal of Leprosy, 32 (1964), 330–331; and Gerhard Henrik Armauer Hansen. l841–1912 (Oslo, 1968), with a bibliography (51 references) and two appendixes, all of which have incomplete listings of Hansen’s work.
T. M. Vogelsang
Cite this article
Pick a style below, and copy the text for your bibliography.
|
MEIJI UNIVERSITY CHOOSES THOMSON SCIENTIFIC'S CENTURY OF SCIENCE.
News Wire article from: AsiaPulse News; 3/3/2008; 700+ words
; ...details below.) MEDIA RELEASE PR29458 Meiji University Chooses Thomson Scientific...March 3 /PRNewswire-AsiaNet/ -- Meiji is the First Private University in Japan...of Science(TM) has been purchased by Meiji University in Japan, expanding its subscription...
|
|
Meiji University eyes the Middle East
Newspaper article from: New Straits Times; 5/10/2009; ; 700+ words
; ...Michael Sun New Straits Times 05-10-2009 Meiji University eyes the Middle East Byline...New Sunday Times Section: Learning Curve MEIJI University has plans for Malaysia to be...the Islamic world, writes MICHAEL SUN. Meiji University's globalised strategy in Malaysia...
|
|
Meiji University Chooses Thomson Scientific's Century of Science.
PR Newswire Europe; 3/3/2008; 700+ words
; ...and LONDON, March 3 /PRNewswire/ -- - Meiji is the First Private University in Japan...of Science(TM) has been purchased by Meiji University in Japan, expanding its subscription...Century of Science is right in line with Meiji University's goals to provide access...
|
|
Amalyte and Meiji Enter Into a License, Development and Commercialization Agreement on AM3301 and a Novel Class of Anti-Inflammatory Compounds.
Business Wire; 6/7/2009; 700+ words
; ...entered into a worldwide strategic alliance with Meiji Seika Kaisha Ltd. (Meiji) to discover, develop and commercialize a lead...except in Japan and several Asian countries where Meiji has a development and commercialization option for...
|
|
A.M. BEST AFFIRMS RATINGS OF MEIJI YASUDA LIFE INSURANCE COMPANY.
News Wire article from: AsiaPulse News; 2/1/2007; 700+ words
; ...details below.) A.M. Best Affirms Ratings of Meiji Yasuda Life Insurance Company OLDWICK, N.J...Excellent) and the issuer credit rating of "a" of Meiji Yasuda Life Insurance Company (Meiji Yasuda) (Japan). The outlook for both ratings...
|
|
Meiji Yasuda's predecessor accused of hiding taxable income.
Newspaper article from: Kyodo News International (Tokyo, Japan); 5/1/2005; 700+ words
; ...TOKYO -- Tax authorities have charged Meiji Life Insurance Co., one of the two predecessors of Meiji Yasuda Life Insurance Co., with hiding...the insurer that the money, which it said Meiji Life had paid to Commerz Securities as rebate...
|
|
ACADIA Pharmaceuticals and Meiji Seika Kaisha Form Collaboration to Develop and Commercialize a New Class of Pro-Cognitive Schizophrenia Drugs.
Business Wire; 3/25/2009; 700+ words
; Meiji Seika Granted Rights to Develop and Commercialize...Pharmaceuticals Inc. (Nasdaq:ACAD) and Meiji Seika Kaisha, Ltd. (TSE:2202) today...a strategic therapeutic focus area for Meiji Seika," said Osamu Makabe, Ph.D...
|
|
Meiji Yasuda Life Insurance Company - SWOT Analysis.
M2 Presswire; 5/7/2009; 700+ words
; ...2009-www.companiesandmarkets.com: Meiji Yasuda Life Insurance Company - SWOT Analysis...companiesandmarkets.com adds new report: Meiji Yasuda Life Insurance Company - SWOT Analysis This Meiji Yasuda Life Insurance Company - SWOT Analysis...
|
|
Kosan Announces Research Collaboration with Meiji Seika Kaisha, Ltd.
Business Wire; 10/16/2001; 700+ words
; ...entered into a research collaboration with Meiji Seika Kaisha, Ltd., a leading pharmaceutical...of technology to manipulate genes of a Meiji bacterium that produces a polyketide...to be working in this pilot project with Meiji, which is a leader in the manufacturing...
|
|
JAPAN'S MEIJI SEIKA TO STRENGTHEN CHINA DRUG OPS.
News Wire article from: AsiaPulse News; 1/27/2005; 659 words
; TOKYO, Jan 27 Asia Pulse - Meiji Seika Kaisha Ltd. (TSE:2202) plans...Positioning China as a vital market, Meiji Seika will strive to increase its pharmaceutical...yen (US$96.9 million) in 2009. Meiji Lukang Pharmaceutical Co., in which...
|
|
Meiji Seika Kaisha, Ltd.
Book article from: International Directory of Company Histories
Meiji Seika Kaisha, Ltd. 4-16, Kyobashi 2...a manufacturer of biscuits and caramels, Meiji Seika Kaisha today is one of Japan ’...other foods, as well as pharmaceuticals. Meiji has applied its technological strengths aggressively...
|
|
Meiji Dairies Corporation
Book article from: International Directory of Company Histories
Meiji Dairies Corporation 1-2-10 Shinsuna Koto-ku Tokyo, 136...Manufacturing; 311520 Ice Cream and Frozen Dessert Manufacturing Meiji Dairies Corporation, formerly known as Meiji Milk Products Company Ltd., is Japan's leading dairy products...
|
|
Meiji Milk Products Company, Limited
Book article from: International Directory of Company Histories
Meiji Milk Products Company, Limited 3-6, Kyobashi...billion) Stock Index: Tokyo Osaka Nagoya Meiji Milk Products Company, Limited, the company...dairy products for its future development. Meiji ’ s sales of infant formula and...
|
|
Meiji Seika Kaisha Ltd.
Book article from: International Directory of Company Histories
Meiji Seika Kaisha Ltd. 4-16, Kyobashi 2...a manufacturer of biscuits and caramels, Meiji Seika Kaisha Ltd. is one of Japan's leading...Japan allowed to sell contraceptive pills. Meiji operates three main business segments...
|
|
The Meiji Mutual Life Insurance Company
Book article from: International Directory of Company Histories
The Meiji Mutual Life Insurance Company 1-1, Marunouchi...09 trillion (US$70.16 billion) The Meiji Mutual Life Insurance Company, Japan...000 agents and 322 group representatives, Meiji Mutual is one of the world ’ s...
|